Show simple item record

dc.contributor.authorAdams, Volker
dc.contributor.authorWunderlich, Sebastian
dc.contributor.authorMangner, Norman
dc.contributor.authorHommel, Jennifer
dc.contributor.authorEsefeld, Katrin
dc.contributor.authorGielen, Stephan
dc.contributor.authorHalle, Martin
dc.contributor.authorEllingsen, Øyvind
dc.contributor.authorVan Craenenbroeck, Emeline M.
dc.contributor.authorWisløff, Ulrik
dc.contributor.authorPieske, Burkert
dc.contributor.authorLinke, Axel
dc.contributor.authorWinzer, Ephraim
dc.date.accessioned2023-01-12T10:09:54Z
dc.date.available2023-01-12T10:09:54Z
dc.date.created2021-12-02T14:24:40Z
dc.date.issued2021
dc.identifier.citationESC Heart Failure. 2021, 8 (4), 2556-2568.en_US
dc.identifier.issn2055-5822
dc.identifier.urihttps://hdl.handle.net/11250/3042941
dc.description.abstractBackground Skeletal muscle (SM) alterations contribute to exercise intolerance in heart failure patients with preserved (HFpEF) or reduced (HFrEF) left ventricular ejection fraction (LVEF). Protein degradation via the ubiquitin-proteasome-system (UPS), nuclear apoptosis, and reduced mitochondrial energy supply is associated with SM weakness in HFrEF. These mechanisms are incompletely studied in HFpEF, and a direct comparison between these groups is missing. Methods and results Patients with HFpEF (LVEF ≥ 50%, septal E/e′ > 15 or >8 and NT-proBNP > 220 pg/mL, n = 20), HFrEF (LVEF ≤ 35%, n = 20) and sedentary control subjects (Con, n = 12) were studied. Inflammatory markers were measured in serum, and markers of the UPS, nuclear apoptosis, and energy metabolism were determined in percutaneous SM biopsies. Both HFpEF and HFrEF showed increased proteolysis (MuRF-1 protein expression, ubiquitination, and proteasome activity) with proteasome activity significantly related to interleukin-6. Proteolysis was more pronounced in patients with lower exercise capacity as indicated by peak oxygen uptake in per cent predicted below the median. Markers of apoptosis did not differ between groups. Mitochondrial energy supply was reduced in HFpEF and HFrEF (complex-I activity: −31% and −53%; malate dehydrogenase activity: −20% and −29%; both P < 0.05 vs. Con). In contrast, short-term energy supply via creatine kinase was increased in HFpEF but decreased in HFrEF (47% and −45%; P < 0.05 vs. Con). Conclusions Similarly to HFrEF, skeletal muscle in HFpEF is characterized by increased proteolysis linked to systemic inflammation and reduced exercise capacity. Energy metabolism is disturbed in both groups; however, its regulation seems to be severity-dependent.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleUbiquitin-proteasome-system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEFen_US
dc.title.alternativeUbiquitin-proteasome-system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEFen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber2556-2568en_US
dc.source.volume8en_US
dc.source.journalESC Heart Failureen_US
dc.source.issue4en_US
dc.identifier.doi10.1002/ehf2.13405
dc.identifier.cristin1963516
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal